Re:BioNTech CEO applies Covid-19 vaccine's mRNA tech to mult...
by usehackernews on Wednesday January 13, 2021 @11:05AM
(#25763818)
I state that CRISPR benefits researchers. However, that is still a niche benefit relative to the long term societal benefits we anticipate from CRISPR.
That's a bit like saying containers haven't provided meaningful economic contribution because consumers don't use them very often.